Torrent Pharma Q3 revenue from operations increased 17.7 per cent year-on-year (Y-o-Y) to ₹3,251 crore from ₹2,762 crore in ...

ICICI Securities recommended hold rating on Torrent Pharma with a target price of Rs 4150 in its research report dated February 16, 2026.

Torrent Pharmaceuticals shares jumped as much as 6 per cent in early trade to hit a record high of Rs 4,322.80. The stock ...

Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated 14, 2026.

Several dividend-paying stocks in India are set to trade ex-dividend today on February 18th. Key companies in focus include Torrent Pharma, Oil India, ONGC, HAL, and Coal India.

Torrent Pharma share price jumped 6% after the company reported a 26.2 per cent jump in its net profit to ₹635 crore in Q3FY26. On a sequential basis, profit increased 7.4 per cent from ₹591 crore ...

Nuvama has flagged four pharma stocks as top ‘Buy’ picks, citing strong US launches, biosimilars traction and margin ...

Torrent Pharmaceuticals posted a steady set of numbers in the fourth quarter, reinforcing confidence in its growth trajectory and catching the attention of SEBI-registered analyst Lalit Mundhra, who ...

Torrent Pharma Q3 results: Profit jumped 26% YoY to ₹635 crore. Total revenue from operations for the December quarter stood ...

In August, Torrent Pharmaceuticals recalled dozens of lots of over-the-counter cough syrups, nasal sprays and rectal suppositories that put children and adults at risk of bacterial infection. Now, the ...

Torrent and global investment firm KKR announced that Torrent has entered into definitive agreements to acquire controlling stake in J. B. Chemicals and Pharmaceuticals from KKR at an Equity Valuation ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...